Literature DB >> 2972612

The Ly-10 antigen is a marker of mouse-activated T lymphocytes.

M M Chan1, U Hämmerling, O Stutman.   

Abstract

Ly-10.1 is a lymphocyte surface antigen controlled by a gene linked to the Ly-1.1 locus and expressed on activated T helper, T suppressor (Ts), and cytotoxic T lymphocytes (CTL). In this report, we describe the following: 1) Ly-10 is a heterodimeric glycoprotein consisting of a 80,000 heavy and a 34,000 light chain. 2) Although mature CTL are Ly-10+ by negative selection with anti-Ly-10.1 and complement (C), CTL precursors reactive to allogeneic cells are Ly-10-. 3) Similarly, IL-2-producing effector T cells induced by Mls-incompatible cells and semiallogeneic stimulation are eliminated by anti-Ly-10.1 and C after activation but are not eliminated as precursors before activation. 4) In mixed lymphocyte culture with semiallogeneic cells, the frequency of Ly-10.1+ cells was highest on the 2nd to 5th day after stimulation, decreased by the 12th day, and increased after restimulation with fresh antigen as demonstrated by immunofluorescence, C-mediated lysis, and IL-2 production. 5) When spleen cells were treated with anti-Ly-10 and C before concanavalin A (Con A) activation, the suppressive activity in the Con A T blasts was reduced, suggesting that in normal mice, some Ts preexist in a Ly-10+ activated state. These results indicate that Ly-10 is a marker of activation of T cells, not expressed on precursor T cells and whose expression is both transient and dependent on the presence of antigen. The similarities in biochemical and cellular characteristics suggest that Ly-10 is a mouse homologue of the human lymphocyte activation marker 4F2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972612     DOI: 10.1007/bf00355374

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  Inhibition of Na+/Ca2+ exchanger activity in cardiac and skeletal muscle sarcolemmal vesicles by monoclonal antibody 44D7.

Authors:  M Michalak; E J Quackenbush; M Letarte
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

2.  The cells responsible for murine natural cytotoxic (NC) activity: a multi-lineage system.

Authors:  M J Bykowsky; O Stutman
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens.

Authors:  G S Eisenbarth; B F Haynes; J A Schroer; A S Fauci
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

5.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

6.  Induction of proliferation in vitro of resting human natural killer cells: expression of surface activation antigens.

Authors:  L London; B Perussia; G Trinchieri
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

7.  Expression of Lyt-1 by a subset of B lymphocytes.

Authors:  V Manohar; E Brown; W M Leiserson; T M Chused
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

8.  Cell surface glycoproteins involved in the stimulation of interleukin 1-dependent interleukin 2 production by a subline of EL4 thymoma cells. II. Structure, biosynthesis, and maturation.

Authors:  B Lüscher; M Rousseaux; R Lees; H R MacDonald; C Bron
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  Concanavalin A-inducible, interleukin-2-producing T cell hybridoma.

Authors:  L Harwell; B Skidmore; P Marrack; J Kappler
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.